Celldex Therapeutics
CLDX
CLDX
171 hedge funds and large institutions have $1.34B invested in Celldex Therapeutics in 2025 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 63 increasing their positions, 53 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 174 → 171 (-3)
28% less capital invested
Capital invested by funds: $1.86B → $1.34B (-$525M)
65% less call options, than puts
Call options by funds: $2.13M | Put options by funds: $6.12M
Holders
171
Holding in Top 10
3
Calls
$2.13M
Puts
$6.12M
Top Buyers
| 1 | +$58.1M | |
| 2 | +$26.1M | |
| 3 | +$19.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.48M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$8.35M |
Top Sellers
| 1 | -$42.9M | |
| 2 | -$42.4M | |
| 3 | -$15M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.3M |
| 5 |
Goldman Sachs
New York
|
-$9.19M |
